12:32 PM EST, 01/13/2025 (MT Newswires) -- Vera Therapeutics ( VERA ) said Monday it has secured an exclusive license deal with Stanford University for fusion protein targeting BAFF and APRIL, known as VT-109, with therapeutic potential across the spectrum of B cell mediated diseases. Vera said it will develop and market VT-109 in exchange for undisclosed upfront and milestone...

MILAN (Reuters) - An Italian court is expected to decide this week on a request by Telecom Italia's (TIM) top investor Vivendi to annul the former phone monopoly's decision to sell its landline grid to a consortium led by KKR, a source close to the matter said. Vivendi, which holds 24% of TIM, filed a complaint with a Milan court...

(Reuters) - The Los Angeles wildfires, which have reduced entire neighborhoods to smoldering ruins and left an apocalyptic landscape, could become the costliest wildfires in U.S. history in terms of insured losses if analysts' estimates of up to $20 billion materialize. Dangerously high winds were expected to resume on Monday in Los Angeles, potentially hampering efforts to extinguish two stubborn...

12:34 PM EST, 01/13/2025 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) filed a lawsuit against Ascendis Pharma ( ASND ) in the Unified Patent Court in Munich, claiming infringement of European patent EP 3 175 863 B1. The patent covers long-acting variants of C-Type Natriuretic Peptide, BioMarin said Monday in a statement. Ascendis' TransCon CNP investigational product and its...